Skip to main content
Product > BactoBots™


BactoBots™ are synthetic biology engineered bacteria.  These microscopic organisms can perform many activities to include releasing medically important chemicals and killing cancer cells. Shengchang Su, PhD, Li Guo, PhD, Ravi Samy, MD, FACS, and Kumaresh Krishnamoorthy, MD, are developing these technologies. The United States of America’s National Science Foundation (NSF) and Microbial Robotics funded BactoBots™ technology that, in vitro, demonstrates destroying cholesteatoma tumors as an adjunct, or replacement, to skull-based surgery.

Want to save these project details? Download this brief Project Manifest for your convenience!

We Believe

How open science helps researchers succeed

Open access, open data, open source, and other open scholarship practices are growing in popularity and necessity. However, widespread adoption of these practices has not yet been achieved. One reason is that researchers are uncertain about how sharing their work will affect their careers. We review literature demonstrating that open research is associated with increases in citations, media attention, potential collaborators, job opportunities, and funding opportunities. These findings are evidence that open research practices bring significant benefits to researchers relative to more traditional closed practices.